AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Teva Pharmaceutical Industries Ltd. Director's Dealing 2015

Mar 27, 2015

7082_dirs_2015-03-27_b172817e-0ac6-4840-a32f-60e327a78f20.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Ignyta, Inc. (RXDX)
CIK: 0001557421
Period of Report: 2015-03-17

Reporting Person: CEPHALON INC (10% Owner)
Reporting Person: TEVA PHARMACEUTICAL INDUSTRIES LTD (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3000000	Direct

Footnotes

F1: Cephalon, Inc. is an indirect wholly owned subsidiary of Teva Pharmaceutical Industries Limited